Unknown

Dataset Information

0

The current state of targeted therapy in melanoma: this time it's personal.

ABSTRACT: Treatment of metastatic melanoma has long been a challenge. Over the past 8 years significant advances have been made in understanding the genetic changes that drive melanoma development and progression. These studies have shown melanoma to be a heterogeneous group of tumors, driven by a diverse array of oncogenic mutations. There is now good evidence that activating mutations in the serine/threonine kinase BRAF and the receptor tyrosine kinase KIT constitute good therapeutic targets for restricted subgroups of melanoma. In this article, we discuss the genetics and etiology of cutaneous and noncutaneous melanoma and review some of the latest preclinical and clinical data on the new targeted therapy agents that are beginning to make an impact on the lives of melanoma patients.

SUBMITTER: Smalley KS 

PROVIDER: S-EPMC3322364 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The current state of targeted therapy in melanoma: this time it's personal.

Smalley Keiran S M KS   McArthur Grant A GA  

Seminars in oncology 20120401 2

Treatment of metastatic melanoma has long been a challenge. Over the past 8 years significant advances have been made in understanding the genetic changes that drive melanoma development and progression. These studies have shown melanoma to be a heterogeneous group of tumors, driven by a diverse array of oncogenic mutations. There is now good evidence that activating mutations in the serine/threonine kinase BRAF and the receptor tyrosine kinase KIT constitute good therapeutic targets for restric  ...[more]

Similar Datasets

Unknown Current State of Target Treatment in BRAF Mutated Melanoma.
| S-EPMC7371970 | biostudies-literature
Unknown Adjuvant Therapy of Uveal Melanoma: Current Status.
| S-EPMC4864524 | biostudies-literature
Unknown Current State of Compassionate Phage Therapy.
| S-EPMC6521059 | biostudies-literature
Unknown It's personal: biology instructors prioritize personal evidence over empirical evidence in teaching decisions.
| S-EPMC4353082 | biostudies-other
Unknown HIV Physicians and Chronic Opioid Therapy: It's Time to Raise the Bar.
| S-EPMC6610859 | biostudies-literature
Unknown Targeted therapy strategies for melanoma brain metastasis.
| S-EPMC8633745 | biostudies-literature
Unknown Signal pathways of melanoma and targeted therapy.
| S-EPMC8685279 | biostudies-literature
Unknown The current state of targeted agents in rectal cancer.
| S-EPMC3362864 | biostudies-literature
Unknown The GIST of targeted therapy for malignant melanoma.
| S-EPMC4041068 | biostudies-literature
Unknown Targeted Therapy in Melanoma and Mechanisms of Resistance.
| S-EPMC7369697 | biostudies-literature